Cargando…

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Potluri, Rahul, Miller, Christopher A, Schmitt, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304837/ http://dx.doi.org/10.1186/1532-429X-14-S1-P166

Ejemplares similares

Is there concordance between LV fibrosis and RV fibrosis in patients with hypertrophic cardiomyopathy; should there be?
por: Amin, Nessim N, et al.
Publicado: (2014)

Synthetic LGE derived from cardiac T(1 )mapping for simultaneous assessment of focal and diffuse cardiac fibrosis
por: Hong, Kyungpyo, et al.
Publicado: (2014)

Diffuse myocardial fibrosis, but not focal fibrosis identified with delayed enhancement, is an independent predictor of LV reversed remodeling in patients with idiopathic non-ischemic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2013)

Sarcoidosis; is it confined to just the LV? An RV LGE study
por: Samar, Huma Y, et al.
Publicado: (2014)

Size of myocardial fibrosis by LGE, pre- and post-contrast T1 and ECV in patients with hypertrophic cardiomyopathy referenced to normal appearing myocardium or healthy volunteers
por: Avanesov, Maxim, et al.
Publicado: (2015)

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Does RV fibrosis have an effect on mortality in patients hypertrophic cardiomyopathy? An LV vs. RV national death index (NDI) study
por: Biederman, Robert W, et al.
Publicado: (2015)

A systematic review for sudden cardiac death in hypertrophic cardiomyopathy patients with myocardial fibrosis: a CMR LGE study
por: Silva, Nackle J, et al.
Publicado: (2012)

Relationship between myocardial scar and hypertrophy by LGE CMR in hypertrophic cardiomyopathy patients with and without clinical events
por: Kino, Aya, et al.
Publicado: (2012)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Regional diffuse fibrosis and strain characteristics differ between children with hypertrophic and dilated cardiomyopathy
por: Patel, Jyoti K, et al.
Publicado: (2015)

3D LGE imaging of the LV short axis stack using spiral readouts at 3T
por: Pierce, Iain, et al.
Publicado: (2014)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Assessment of prognostic LV parameters with CMR in hypertrophic cardiomyopathy: impact of the papillary muscles
por: Gommans, Frank, et al.
Publicado: (2012)

Fibrotic content of LV myocardium quantified by CMR characterizes left atrial sizes and total left atrial emptying function incremental to LV functional parameters and LV myocardial mass index in patients with hypertrophic cardiomyopathy
por: Chen, Yucheng, et al.
Publicado: (2012)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Delayed myocardial enhancement in pediatric hypertrophic cardiomyopathy: correlation with LV functional and demographic parameters
por: Behairy, Noha, et al.
Publicado: (2016)

Myocardial fibrosis by CMR LGE in a large cohrt of pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
por: Tham, Edythe B, et al.
Publicado: (2011)

Comparison of Gadopentetate dimeglumine and Gadobenate dimeglumine in depiction of non-ischemic fibrosis in hypertrophic cardiomyopathy
por: Rudolph, Andre, et al.
Publicado: (2009)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

If there is LV myocardial fibrosis should we expect to find RV myocardial fibrosis? A cardiovascular MRI study
por: Biederman, Robert W, et al.
Publicado: (2012)

Diffuse Myocardial Fibrosis detected by Multi-slice T(1) Mapping using Slice Interleaved T(1) (STONE) Sequence in Patients with Hypertrophic Cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2016)

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

Assessment of myocardial and LV blood pool post-contrast T1 evolution: comparison between healthy subjects and patients with hypertrophic cardiomyopathy
por: Kachenoura, Nadjia, et al.
Publicado: (2013)

Initial evidence of presence of papillary muscle diffuse fibrosis in patients with cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2015)

Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
por: Avanesov, Maxim, et al.
Publicado: (2016)

Progression of myocardial fibrosis and functional clinical status in Hypertrophic Cardiomyopathy: a study with cardiac magnetic resonance
por: Todiere, Giancarlo, et al.
Publicado: (2011)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

Cardiac ECV is more robust than post-contrast cardiac T(1 )for evaluating temporal changes in LV fibrosis
por: Hong, Kyungpyo, et al.
Publicado: (2014)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
por: Han, Yuchi, et al.
Publicado: (2009)

Extent of late gadolinium enhancement in patients with hypertrophic cardiomyopathy in correlation with serum MMP9 as an indicator of myocardial fibrosis
por: Avanesov, Maxim, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

LGE in pulmonary hypertension predicts clinical events
por: Soma, Siva, et al.
Publicado: (2011)

Multiplanar 4D strain analysis with spatial mapping to 3D LGE quantification: relationships in chronic Ischemic Cardiomyopathy
por: Satriano, Alessandro, et al.
Publicado: (2015)

CMR assessment of myocardial mechanics and tissue characterization in patients treated with Anthracycline chemotherapy for acute myeloid leukaemia
por: Miller, Christopher A, et al.
Publicado: (2012)

First-pass stress perfusion MR Imaging findings of apical hypertrophic cardiomyopathy: with relation to LV wall thickness and late Gadolinium-enhancement
por: Yoo, Jin Young, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lceu2q1v1k0b39iccc8o45shoc